IPO Issue Details
Issue Price / Price Band₹135 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,000 Shares per Lot
Total Issue Size57,40,000 shares (agg. up to ₹77 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenWed, 21 Jan 2026
Subscription CloseFri, 23 Jan 2026
Anchor AllotmentTue, 20 Jan 2026
Basis of AllotmentTue, 27 Jan 2026
Initiation of RefundsWed, 28 Jan 2026
Credit of Shares to DematWed, 28 Jan 2026
Listing DateThu, 29 Jan 2026
UPI Mandate Deadline5:00 PM on 23 Jan 2026 (Day 3)
Application & Investment Details
Retail — Min (2 Lots)₹2,70,000 — 2,000 shares
Retail — Max (13 Lots)₹1,755,000 (13 Lots)
HNI — Min (3 Lots)₹4,05,000 — 3,000 shares
EPS (Pre-IPO)₹7.79
EPS (Post-IPO)₹5.69
P/E Ratio (Pre-IPO)17.32x
P/E Ratio (Post-IPO)23.73x
Net Offer to Public51,66,000 shares (agg. up to ₹70 Cr)
Reserved for Market Maker5,74,000 shares (agg. up to ₹8 Cr)
Pre-IPO Promoter Holding1,55,20,800 shares
Post-IPO Promoter Holding2,12,60,800 shares
About KRM Ayurveda Ltd
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales.They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care / wellness related items.Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country.Services & Products:HospitalsClinicTeleconsultation ServicesKRM Ayurveda ProductsAs on August 31, 2025, the company have total of 429 employees operating under various departments.Competitive Strengths:Skilled Ayurvedic physicians and certified therapists ensuring treatment quality.Centralized GMP-certified production of Ayurvedic medicines ensuring purity and efficacy.Trusted brand with loyal customer base and repeat clientele.
Objects of the Issue
KRM Ayurveda Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Capital Expenditure for Construction and Development of Telemedicine Operational Facilities
13.67
2
Purchase of CRM Software and Hardware Infrastructure
1.42
4
Repayment/Prepayment of loan
12.50
5
Working Capital Requirement
22.90
6
General Corporate Purposes
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,55,20,800 shares
Post-IPO Promoter Holding
2,12,60,800 shares